Distribution of ß-Lactamase Genes Among Multidrug-Resistant and Extended-Spectrum ß-Lactamase-Producing Diarrheagenic Escherichia coli from Under-Five Children in Ethiopia

被引:3
|
作者
Zenebe, Tizazu [1 ,2 ]
Eguale, Tadesse [3 ,4 ]
Desalegn, Zelalem [1 ]
Beshah, Daniel [5 ]
Gebre-Selassie, Solomon [1 ]
Mihret, Adane [1 ,6 ]
Abebe, Tamrat [1 ]
机构
[1] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia
[2] Debre Berhan Univ, Dept Med Lab Sci, POB 445, Debre Berhan, Ethiopia
[3] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia
[4] Ohio State Univ, Global One Hlth LLC, Addis Ababa, Ethiopia
[5] Addis Ababa Univ, Tikur Anbessa Specialized Hosp, Dept Med Lab, Addis Ababa, Ethiopia
[6] Armauer Hansen Res Inst AHRI, Bacterial & Viral Dis Res Directorate, Addis Ababa, Ethiopia
来源
关键词
Diarrheagenic E. coil; under-five children; 13-lactamase; carbapenemase; ESBL; multidrug resistance; Ethiopia; BETA-LACTAMASES; MOLECULAR CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; PREVALENCE; PATTERN;
D O I
10.2147/IDR.S432743
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose: Escherichia coli strains that produce extended-spectrum 13-lactamase (ESBL) and carbapenemase are among the major threats to global health. The objective of the present study was to determine the distribution of 13-lactamase genes among multidrug-resistant (MDR) and ESBL-producing Diarrheagenic E. coli (DEC) pathotypes isolated from under-five children in Ethiopia.Patients and Methods: A cross-sectional study was conducted in Addis Ababa and Debre Berhan, Ethiopia. It was a health-facility -based study and conducted between December 2020 and August 2021. A total of 476 under-five children participated in the study. DEC pathotypes were detected by conventional Polymerase Chain Reaction (PCR) assay. After evaluating the antimicrobial suscept-ibility profile of the DEC strains by disk diffusion method, confirmation test was done for ESBL and carbapenemase production. 13-lactamase encoding genes were identified from phenotypically ESBLs and carbapenemase positive DEC strains using PCR assay.Results: In total, 183 DEC pathotypes were isolated from the 476 under-five children. Seventy-nine (43%, 79/183) MDR-DEC pathotypes were identified. MDR was common among enteroaggregative E. coli (EAEC) (58%, 44/76), followed by enterotoxigenic E. coli (ETEC) (44%, 17/39)) and enteroinvasive E. coli (EIEC) (30%, 7/23). Phenotypically, a total of 30 MDR-DEC pathotypes (16.4%, 30/183) were tested positive for ESBLs. Few ETEC (5.1%, 2/39) and EAEC (2.6%, 2/76) were carbapenemase producers. The predominant beta-lactamase genes identified was blaTEM (80%, 24/30) followed by blaCTX-M (73%, 22/30), blaSHV (60%, 18/30), blaNDM (13%, 4/30), and blaOXA-48 (13%, 4/30). Majority of the 13-lactamase encoding genes were detected in EAEC (50%) and ETEC (20%). Co-existence of different beta-lactamase genes was found in the present study.Conclusion: The blaTEM, blaCTX-M, blaSHV, blaNDM, and blaOXA-48, that are associated with serious and urgent threats globally, were detected in diarrheagenic E. coli isolates from under-five children in Ethiopia. This study also revealed the coexistence of the beta-lactamase genes.
引用
收藏
页码:7041 / 7054
页数:14
相关论文
共 50 条
  • [1] Genomic characterisation of extended-spectrum β-lactamase-producing multidrug-resistant Escherichia coli in Rabat, Morocco
    Ambroise, Jerome
    Benaissa, Elmostafa
    Irenge, Leonid Mwana Wa Bene
    Belouad, El Mehdi
    Bearzatto, Bertrand
    Durant, Jean-Francois
    Badir, Jamal
    Elouennass, Mostafa
    Gala, Jean-Luc
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 26 : 335 - 341
  • [2] Prevalence of multidrug-resistant and extended-spectrum β-lactamase-producing Escherichia coli from chicken farms in Egypt
    Salem, Gamal A.
    Abdelaziz, El-Sayed A.
    Kamel, Mohammed A.
    Rhouma, Nasreddin R.
    Ali, Reem I.
    VETERINARY WORLD, 2023, 16 (05) : 1001 - 1007
  • [3] Extended-spectrum β-lactamase-producing Escherichia coli
    Sloth, Louise B.
    Hargreaves, Sally
    Nellums, Laura B.
    Nielsen, Rikke T.
    Norredam, Marie
    LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 405 - 405
  • [4] Isolation and prevalence of multidrug-resistant extended-spectrum β-lactamase-producing E. Coli from adults and children
    Abo-Amer, Aly E.
    Moubasher, Hani
    Sliai, Salam
    BIOSCIENCE RESEARCH, 2019, 16 (02): : 888 - 897
  • [5] Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated from Vegetable Farm Soil in South Korea
    Song, Jihyun
    Kim, Junghee
    Oh, Sung-Suck
    Shin, Jinwook
    MICROBIAL DRUG RESISTANCE, 2021, 27 (11) : 1489 - 1494
  • [6] Widespread dissemination of extended-spectrum β-lactamase-producing, multidrug-resistant escherichia coli in livestock and fishery products in Vietnam
    Le H.V.
    Kawahara R.
    Khong D.T.
    Tran H.T.
    Nguyen T.N.
    Pham K.N.
    Jinnai M.
    Kumeda Y.
    Nakayama T.
    Ueda S.
    Yamamoto Y.
    International Journal of Food Contamination, 2 (1):
  • [7] Detection of extended-spectrum β-lactamase-producing, multidrug-resistant environmental isolates of Escherichia coli that bind to human bladder cells
    Hong, HG
    Chun, JY
    Lee, Y
    MICROBIAL DRUG RESISTANCE, 2004, 10 (02) : 184 - 189
  • [8] Molecular Characterization of Extended-Spectrum β-Lactamase-Producing Multidrug Resistant Escherichia coli From Swine in Northwest China
    Liu, Xiaoqiang
    Liu, Haixia
    Wang, Le
    Peng, Qian
    Li, Yinqian
    Zhou, Hongchao
    Li, Qinfan
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [9] Extended-spectrum β-lactamase-producing Escherichia coli from poultry: A review
    Widodo, Agus
    Khairullah, Aswin Rafif
    Effendi, Mustofa Helmi
    Moses, Ikechukwu Benjamin
    Agustin, Alfiana Laili Dwi
    VETERINARY WORLD, 2024, 17 (09) : 2017 - 2027
  • [10] Fosfomycin Susceptibility Among Multidrug-Resistant Extended-Spectrum β-Lactamase and Metallo-β-Lactamase-Producing Uropathogens in a Tertiary Care Hospital
    Kothari, Aditi
    Chaturvedi, Parul
    Bhumbla, Upasana
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2024, 32 (03)